This evidence, drawn from several major clinical trials, reveals that GLP-1 RAs like Semaglutide and Tirzepatide can significantly reduce the risk of cardiovascular events, chronic kidney disease, and liver disease while improving conditions like sleep apnea and osteoarthritis
Sources Raizada, K., & Margolin, E
Vi kh nng iu phi tinh t gia tiu ha v chuyn ha, GLP-1 khng ch l mt tn hiu sinh hc n thun m cn l v kh sinh hc c ng dng mnh m trong iu tr tiu ng type 2 , bo ph , v mt s ri lon chuyn ha khc
10.1016/S2213-8587(16)30323-0 81 ShahR.GargR.MajmundarM.PurandareN.MalhotraG.PatilV.et al (2021)
Please note: This test requires a fasted blood sample
Zepbound (Tirzepatide) Zepbound is an innovative option for Michigan residents pursuing enhanced weight loss